Injection site and risk of medically attended local reactions to acellular pertussis vaccine

Pediatrics

Volumn 127, Issue 3, 2011, Pages

  Jackson, Lisa A ^a   Yu, Onchee ^a   Nelson, Jennifer C ^a,b   Dominguez, Clara ^a,b   Peterson, Do ^a   Baxter, Roger ^c   Hambidge, Simon J ^c   Naleway, Allison L ^c   Belongia, Edward A ^d   Nordin, James D ^e   Baggs, James ^f  

^a GROUP HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c KAISER PERMANENTE   (United States)

^d MARSHFIELD CLINIC   (United States)

^e HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Diphtheria tetanus acellular pertussis vaccines; Injections; Intramuscular

Indexed keywords

DIPHTHERIA TETANUS TOXOID; PERTUSSIS VACCINE;

ARM; ARTICLE; CHILD; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HUMAN; INJECTION; INJECTION SITE; INJECTION SITE INFECTION; LOCAL SKIN REACTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; PERTUSSIS; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; THIGH; VACCINATION;

ARM; CHILD; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERSENSITIVITY; INCIDENCE; INJECTIONS, INTRAMUSCULAR; MALE; RETROSPECTIVE STUDIES; SKIN; THIGH; UNITED STATES; WHOOPING COUGH;

EID: 79952227365     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-1886     Document Type: Article

References (15)

1. Kroger AT, Atkinson WL, Marcuse EK, Pickering LK. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-15):1-48
2. American Academy of Pediatrics Committee on Infectious Diseases. Active and passive immunization. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009: 1-104. Available at: http://aapredbook.aappublications.org/current.dtl. Accessed December 11, 2010
3. Ipp MM, Gold R, Goldbach M, et al. Adverse reactions to diphtheria, tetanus, pertussis-polio vaccination at 18 months of age: effect of injection site and needle length. Pediatrics. 1989;83(5):679-682 (Pubitemid 19120508)
4. Scheifele DW, Halperin SA, Ochnio JJ, Ferguson AC, Skowronski DM. A modified vaccine reduces the rate of large injection site reactions to the preschool booster dose of diphtheria-tetanus-acellular pertussis vaccine: results of a randomized, controlled trial. Pediatr Infect Dis J. 2005;24(12):1059-1066 (Pubitemid 43011060)
5. Tozzi AE, Anemona A, Stefanelli P, et al. Reactogenicity and immunogenicity at preschool age of a booster dose of 2 3-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccines. Pediatrics. 2001;107(2):E25
6. Skowronski DM, Remple VP, Macnabb J, et al. Injection-site reactions to booster doses of acellular pertussis vaccine: rate, severity, and anticipated impact. Pediatrics. 2003;112(6 pt 1):e453
7. Langley JM, Predy G, Guasparini R, et al. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine. Vaccine. 2007;25(6):1121-1125 (Pubitemid 44937444)
8. Jackson LA, Starkovich P, Dunstan M, et al. Prospective assessment of the effect of needle length and injection site on the risk of local reactions to the fifth diphtheria-tetanus-acellular pertussis vaccination. Pediatrics. 2008;121(3):e646-52
9. Chen RT, DeStefano F, Davis RL, et al. The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA. Bull World Health Organ. 2000;78(2):186-194 (Pubitemid 30151603)
10. DeStefano F; Vaccine Safety Datalink Research Group. The Vaccine Safety Datalink project. Pharmacoepidemiol Drug Saf. 2001;10(5):403-406
11. Jackson LA, Yu O, Nelson J, et al. Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study. Vaccine. 2009;27(36):4912-4916
12. Jackson LA, Yu O, Belongia EA, et al. Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study. BMC Infect Dis. 2009;9:165
13. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85(9):660-667 (Pubitemid 47416716)
14. World Health Organization. Application tools: WHO AnthroPlus software. Available at: www.who.int/growthref/tools/en. Accessed June 22, 2010
15. World Health Organization Multicentre Growth Reference Study Group. WHO Child Growth Standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. Available at: www.who.int/childgrowth/standards/technical-report/ en/index.html. Accessed June 22, 2010